Does an intra-articular steroid injection affect the post-bronchodilator response in pulmonary function testing?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 13, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Intra-Articular Steroid Injections Do Not Affect Post-Bronchodilator Results in Human Pulmonary Function Testing

There is no evidence that intra-articular steroid injections affect post-bronchodilator spirometry results in humans. The provided guidelines focus exclusively on factors that should be controlled before bronchodilator testing—specifically the timing of inhaled bronchodilators, long-acting β-agonists, and sustained-release theophyllines—but make no mention of systemic or intra-articular corticosteroid administration as a confounding factor 1, 2, 1.

Key Points About Bronchodilator Testing Protocols

Pre-Test Requirements

According to established guidelines, patients should avoid 1:

  • Short-acting inhaled bronchodilators for 6 hours prior
  • Long-acting β-agonists for 12 hours prior
  • Sustained-release theophyllines for 24 hours prior
  • Testing should occur when patients are clinically stable and free from infection

What Constitutes a Significant Response

A positive bronchodilator response is defined as 1, 2:

  • FEV₁ increase >200 mL AND >12-15% from baseline
  • Both absolute and percentage criteria must be met
  • Changes <8% or <150 mL are within measurement variability

Why Intra-Articular Steroids Are Not a Concern

The distinction between bronchodilator testing and corticosteroid reversibility testing is critical here:

Bronchodilator Testing

  • Measures immediate airway smooth muscle relaxation (15-30 minutes post-administration)
  • Assesses β-agonist or anticholinergic response
  • Used for diagnosis and establishing baseline post-bronchodilator FEV₁ 1

Corticosteroid Reversibility Testing

  • Requires 2 weeks of oral prednisolone (30 mg/day) or 6 weeks of inhaled steroids 1
  • Measures anti-inflammatory effects on airway remodeling
  • This is an entirely separate test from acute bronchodilator response

Intra-articular steroid injections would not interfere with the acute bronchodilator response being measured in standard post-bronchodilator spirometry, as bronchodilators work through immediate smooth muscle relaxation, not anti-inflammatory mechanisms.

Clinical Context

The single animal study provided 3 showed that intra-articular methylprednisolone improved lung function in severely asthmatic horses, but this represents the systemic anti-inflammatory effect of corticosteroids—not an interaction with bronchodilator testing. This effect took 24 hours to manifest and was measuring a different physiological response entirely.

Common Pitfall to Avoid

Do not confuse corticosteroid reversibility testing (which measures inflammatory response over weeks) with bronchodilator testing (which measures immediate smooth muscle response). These assess completely different mechanisms and timeframes 1.

Bottom line: Proceed with post-bronchodilator spirometry testing regardless of recent intra-articular steroid injection. No washout period or timing adjustment is necessary, as these injections do not affect the acute bronchodilator response being measured 1, 2, 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.